U.S., Japan Regenerative Medicine Groups Forge Closer Ties
This article was originally published in The Gray Sheet
Executive Summary
A major international regenerative medicine group has taken steps to more closely collaborate with a counterpart in Japan, which is prioritizing the development of the sector as a strategic national priority, to improve coordination and information exchange.
You may also be interested in...
Regenerative Medicine Sector ARMs Itself With New Advocacy Group
Companies and researchers developing cell-based and tissue engineering therapies have formed a lobbying group to improve the federal policy environment surrounding their efforts
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.